| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
60,492,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,682,564 |
Avg
Vol: |
2,636,078 |
| 52
Week Range: |
$31.96 - $31.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-08-08 |
4 |
OE |
$2.36 |
$23,600 |
D/D |
10,000 |
58,695 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-08-07 |
4 |
AS |
$27.36 |
$467,825 |
D/D |
(17,100) |
24,567 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-08-07 |
4 |
OE |
$1.18 |
$20,178 |
D/D |
17,100 |
41,667 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-08-02 |
4 |
AS |
$24.96 |
$224,604 |
D/D |
(9,000) |
0 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-08-02 |
4 |
OE |
$1.18 |
$10,620 |
D/D |
9,000 |
9,000 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-08-01 |
4 |
AS |
$24.77 |
$605,619 |
D/D |
(24,450) |
0 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-08-01 |
4 |
OE |
$1.18 |
$28,851 |
D/D |
24,450 |
24,450 |
|
- |
|
| Snyder Kent |
Director |
– • – |
2013-07-15 |
4 |
AS |
$25.36 |
$887,761 |
D/D |
(35,000) |
0 |
|
- |
|
| Snyder Kent |
Director |
– • – |
2013-07-15 |
4 |
OE |
$9.59 |
$335,650 |
D/D |
35,000 |
35,000 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-07-10 |
4 |
AS |
$23.17 |
$440,183 |
D/D |
(19,000) |
166,326 |
|
- |
|
| Crawford Debra P |
Sr. VP, CFO, Secy, Treas |
• – – |
2013-07-10 |
4 |
OE |
$1.18 |
$22,420 |
D/D |
19,000 |
185,326 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-07-09 |
4 |
AS |
$23.52 |
$356,693 |
D/D |
(15,165) |
380 |
|
- |
|
| De Meules Julie A |
Sr. VP, Human Resources |
• – – |
2013-07-09 |
4 |
OE |
$1.18 |
$17,895 |
D/D |
15,165 |
15,545 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-07-08 |
4 |
AS |
$23.22 |
$397,052 |
D/D |
(17,100) |
24,567 |
|
- |
|
| Fox Carey J |
Sr VP, General Counsel |
• – – |
2013-07-08 |
4 |
OE |
$1.18 |
$20,178 |
D/D |
17,100 |
41,667 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-07-08 |
4 |
AS |
$23.34 |
$233,422 |
D/D |
(10,000) |
48,695 |
|
- |
|
| Bedoya-Toro Maria E |
SVP, Regulatory Affairs & QA |
• – – |
2013-07-08 |
4 |
OE |
$2.36 |
$23,600 |
D/D |
10,000 |
58,695 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-07-05 |
4 |
AS |
$21.76 |
$659,416 |
D/D |
(30,301) |
1,497 |
|
- |
|
| Step Michael D |
SVP, Corporate Development |
• – – |
2013-07-05 |
4 |
OE |
$1.18 |
$35,755 |
D/D |
30,301 |
31,798 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-07-03 |
4 |
AS |
$21.54 |
$68,836 |
I/I |
(3,196) |
0 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-07-03 |
4 |
AS |
$21.54 |
$550,363 |
D/D |
(25,553) |
7,630 |
|
- |
|
| Hall Warren E |
Sr. VP, Mfg. & Prod. Dev. |
• – – |
2013-07-03 |
4 |
OE |
$1.18 |
$30,153 |
D/D |
25,553 |
33,183 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-07-02 |
4 |
AS |
$21.45 |
$193,046 |
D/D |
(9,000) |
0 |
|
- |
|
| Ballard E David Ii |
SVP, Med Affairs & Pharmvig |
• – – |
2013-07-02 |
4 |
OE |
$1.18 |
$10,620 |
D/D |
9,000 |
9,000 |
|
- |
|
| Denby William C |
Sr. VP, Commercial Operations |
• – – |
2013-07-01 |
4 |
AS |
$21.56 |
$540,023 |
D/D |
(25,050) |
0 |
|
- |
|
417 Records found
|
|
Page 5 of 17 |
|
|
